CIK 0001818382
- Non-accelerated filer
- Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851763759
- Phone
- +1 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Commercial Officer bought 6,493 shares at $1.54 ($9,999)
- 4 Open-market buy CFO and Chief Corp. Deve. Off. bought 20,000 shares at $1.53 ($30,600)
- 4 Open-market buy Chief Medical Officer bought 7,500 shares at $1.55 ($11,625)
- 4 Open-market buy Director bought 50,000 shares at $1.32 ($66,000)
- 4 Open-market buy Director bought 6,000 shares at $1.29 ($7,740)
- 4 Open-market buy Director bought 16,000 shares at $1.26 ($20,160)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 4,600 shares at $4.39 ($20,181)
- 4 Open-market buy President, CEO and Director bought 1,797 shares at $4.44 ($7,979)
Page 3 of 12 · 235 filings